Despite having the second highest mortality associated with cancer, currently Sorafenib is the only FDA-approved chemotherapeutic agent available for liver cancer patients which can only improve survival for few months. In this study, various pyrazolic chalcone analogous compounds were synthesized and evaluated as potential chemotherapeutic agents for the treatment of hepatocellular carcinoma (HCC). Modifying the central pyrazole ring at the C(3)-position with different heteroaryl rings and substituting the C(4)-position of pyrazole with differently substituted chalcone moiety produced fouthy two variant compounds. For all these compounds, cytotoxicity was evaluated using sulforhodamine B assay and real time cell growth tracking, respectively. Based on 50% inhibitory concentration (IC) values, compounds 39, 42, 49, and 52 were shown to exhibit potent cytotoxic activity against all the cancer cell lines tested, and had better cytotoxic activities than the well-known chemotherapeutic drug 5-FU. Therefore, these compounds were chosen to be further evaluated in a panel of HCC cell lines. Flow cytometric analysis of HCC cells treated with compounds 39, 42, 49, and 52 demonstrated that these compounds caused cell cycle arrest at G2/M phase followed by the apoptotic cell death and impaired cell growth as shown by real-time cell growth surveillance. Consistent with these results, western blotting of HCC cells treated with the compounds resulted in molecular changes for cell cycle proteins, where p21 levels were increased independent of p53 and the levels of the key initiators of mitosis Cyclin B1 and CDK1 were shown to decrease upon treatment. In conclusion, chalcone derivatives 42 and 52 show potent bioactivities by modulating the expression of cell-cycle related proteins and resulting in cell-cycle arrest in the HCC cell lines tested here, indicating that the compounds can be considered as preclinical candidates.
In this study, we synthesized a series of trans-indole-3-acrylamide derivatives (3a–k) and investigated their activity for inhibition of cell proliferation against five human cancer cell lines (HeLa, MCF7, MDA-MB-231, Raji and HL-60) by MTT assay. Compound 3e showed significant antiproliferative activity against both the Raji and HL-60 cell lines with IC50 values of 9.5 and 5.1 µM, respectively. Compound 3e also exhibited moderate inhibitory activity on tubulin polymerization (IC50 = 17 µM). Flow cytometric analysis of cultured cells treated with 3e also demonstrated that the compound caused cell cycle arrest at the G2/M phase in HL-60 and HeLa cells. Moreover, 3e, the most active compound, caused an apoptotic cell death through the activation of caspase-3. Docking simulations suggested that 3e binds to the colchicine site of tubulin.
Chondroitin sulfate E (CS-E) is a
sulfated polysaccharide that
contains repeating disaccharides of 4,6-disulfated
N
-acetylgalactosamine and glucuronic acid residues. Here, we report
the enzymatic synthesis of three homogeneous CS-E oligosaccharides,
including CS-E heptasaccharide (
CS-E 7-mer
), CS-E tridecasaccharide
(
CS-E13-mer
), and CS-E nonadecasaccharide (
CS-E
19-mer
). The anti-inflammatory effect of
CS-E 19-mer
was investigated in this study.
CS-E 19-mer
neutralizes
the cytotoxic effect of histones in a cell-based assay and in mice.
We also demonstrate that
CS-E 19-mer
treatment improves
survival and protects against organ damage in a mouse model of endotoxemia
induced by bacterial lipopolysaccharide (LPS).
CS-E19-mer
directly interacts with circulating histones in the plasma from
LPS-challenged mice.
CS-E 19-mer
does not display anticoagulant
activity nor react with heparin-induced thrombocytopenia antibodies
isolated from patients. The successful synthesis of CS-E oligosaccharides
provides structurally defined carbohydrates for advancing CS-E research
and offers a potential therapeutic agent to treat life-threatening
systemic inflammation.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.